Analysis on the mechanisms of growth, differentiation, and survival of megakaryocytic cells
巨核细胞生长、分化和存活机制分析
基本信息
- 批准号:16209033
- 负责人:
- 金额:$ 29.2万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1.To explore activation mechanism of FLT3 TKD mutation, we analysed critical tyrosine residues for the constitutive activation and downstream signaling of the mutant by generating a series of single Tyr→Phe substitution mutant of all 22 cytoplasmic tyrosine residues of murine FLT3 TKD-mutant (mFLT3Asp838Val). Tyr845Phe, Tyr892Phe and Tyr922Phe substitutions suppressed the phosphorylation of mFLT3Asp838Val itself, the activation of Erk1/2,STAT3 and STAT5, and the factor-independent cell proliferation and survival. In contrast, these three Tyr→Phe mutations partially suppressed but maintained the ligand-dependent activation and anti-apoptotic activity of wild-type FLT3, suggesting that these tyrosine residues were more critical for the constitutive activation and signaling of mFLT3Asp838Val.2.We examined the expression of cell cycle regulatory molecules during Notch- and HOXB4-induced self-renewal of hematopoietic stem cells, and found that both molecules induce the expression of c-myc. … More In addition, we determined that HOXB4 activated the c-my promoter through the element between -195 and -161 bp. We also proved that the induction of c-myc activity alone was sufficient for enhancing self-renewal of hematopoietic stem cells in the presence of appropriate cytokines using Myc/ERT, which reveals c-myc activity in response to 4-hydroxytamoxifen. These results indicated that Notch and HOXB4 induce self-renewal of hematopoietic stem cells through the induction of c-myc.3.We generated knock out mice for Anamorsin. Anamorsin^<-/-> mice are embryonic lethal due to the failure of definitive hematopoiesis in the fetal liver, Although the number of hematopoietic stem/progenitor cells in the fetal liver did not decrease in these mice, myeloid and particularly erythroid colony formation was severely disrupted. Also, Anamorsin^<-/-> erythroid cells initiated apoptosis during terminal maturation. As for the mechanism of Anamorsin-mediated cell survival, a microarray analysis revealed that the expression of Bcl-xL and Jak2 was severely impaired in the fetal liver of Anamorsin^<-/-> mice. Less
1.探索FLT3 TKD突变的激活机制,我们通过生成一系列的22个单个Tyr→PHE取代突变体,分析了突变体组成型酪氨酸残留物,以进行组成型和下游信号传导。 Tyr845Phe,Tyr892Phe和Tyr922PHE取代抑制了Mflt3asp838Val本身的磷酸化,ERK1/2,STAT3和STAT5的激活以及与因子无关的细胞增殖和生存。相反,这三个Tyr→Phe突变部分抑制了野生型FLT3的配体依赖性激活和抗凋亡活性,这表明这些酪氨酸保留的保留更为重要。造血干细胞,发现这两个分子都会影响c-myc的表达。 …此外,我们确定HOXB4通过-195和-161 bp之间的元素激活了C -MY启动子。我们还规定,仅使用MYC/ERT存在适当的细胞因子,仅诱导C-MYC活性就足以增强造血干细胞的自我更新,这揭示了C-MYC活性以响应4-羟基氧莫莫昔芬。这些结果表明,Notch和Hoxb4通过诱导C-Myc诱导造血干细胞的自我更新。3。我们生成的anamorsin敲出小鼠。由于胎儿肝脏中确定的造血性失败,胎儿肝脏中的造血性造血症的失败,胎儿肝中的造血/祖细胞的数量并未减少这些小鼠,髓样本和成类菌落的形成,但在eRy-er rap中均引起了序列,因此在胎儿肝脏/祖细胞中的数量并没有减少,但在胎儿肝脏中的造血干细胞的数量并未降低,在胎儿肝脏中的造血/祖细胞的数量并未降低,在胎儿肝脏中的造血/祖细胞的数量并未降低,在胎儿肝脏中,namorsin^< - / - >小鼠是胚胎致死性的。至于Anamorsin介导的细胞存活的机理,微阵列分析表明,在Anamorsin^< - / - >小鼠的胎儿肝脏中,Bcl-XL和JAK2的表达严重受损。较少的
项目成果
期刊论文数量(54)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inflammation markers and liver dysfunction.
炎症标志物和肝功能障碍。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Kabutomori O;et al.
- 通讯作者:et al.
Differential effects of a novel IFN-ζ/limitin and IFN-α on signals for DAXX induction and Crk phosphorylation that couple with growth control of megakaryocytes.
新型 IFN-ζ/limitin 和 IFN-α 对 DAXX 诱导和 Crk 磷酸化信号的不同影响,与巨核细胞的生长控制相结合。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:Ishida N;et al.
- 通讯作者:et al.
Cell cycle regulation in hematopoietic stem cells.
- DOI:10.1083/jcb.201102131
- 发表时间:2011-11-28
- 期刊:
- 影响因子:0
- 作者:Pietras EM;Warr MR;Passegué E
- 通讯作者:Passegué E
Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies-Co-existence of these antibodies enhances ADP-induced platelet activation in vitr
脑梗塞的患病率与抗心磷脂/β2-糖蛋白 I 和抗磷脂酰丝氨酸/凝血酶原抗体的存在有很强的相关性——这些抗体的共存增强了 ADP 诱导的体外血小板活化
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Nojima J;et al.
- 通讯作者:et al.
Cell cycle regulation in hematopoietic stem/progenitor cells.
- DOI:10.3923/jbs.2005.50.60
- 发表时间:2004
- 期刊:
- 影响因子:4.3
- 作者:S. Ezoe;I. Matsumura;Yusuke Satoh;Hirokazu Tanaka;Y. Kanakura
- 通讯作者:S. Ezoe;I. Matsumura;Yusuke Satoh;Hirokazu Tanaka;Y. Kanakura
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KANAKURA Yuzuru其他文献
KANAKURA Yuzuru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KANAKURA Yuzuru', 18)}}的其他基金
Functional analysis of SATB1, a global transcription regulator, in hematopoietic stem cells
造血干细胞中全局转录调节因子 SATB1 的功能分析
- 批准号:
16H05339 - 财政年份:2016
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of the functions of anti-apoptotic molecule, Anamorsin -the roles in hematopoiesis and cellular iron metabolism-
抗凋亡分子Anamorsin的功能分析-在造血和细胞铁代谢中的作用-
- 批准号:
25293220 - 财政年份:2013
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Screening of low molecular compounds, which inhibit cell proliferation and survival
筛选抑制细胞增殖和存活的低分子化合物
- 批准号:
23659488 - 财政年份:2011
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of functions of anamorsin, an anti-apoptotic molecule, in hematopoiesis
抗凋亡分子阿莫辛的造血功能分析
- 批准号:
22390194 - 财政年份:2010
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Synthetic Analysis on the mechanisms of survival and differentiation of hematopoietic cells
造血细胞存活和分化机制的综合分析
- 批准号:
18209034 - 财政年份:2006
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Analysis of molecular mechanisms of leukemia
白血病分子机制分析
- 批准号:
17016042 - 财政年份:2005
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Analysis on the mechanism of survival, growth and differentiation of hematopoietic cells
造血细胞存活、生长和分化机制分析
- 批准号:
14370302 - 财政年份:2002
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms regulating the growth and differentiation of hematopoietic stem cells
调节造血干细胞生长和分化的分子机制
- 批准号:
12470200 - 财政年份:2000
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Receptor-mediated signalings-regulating proliferation, differentiation and neoplastic transformation of hematopoietic cells
受体介导的信号传导——调节造血细胞的增殖、分化和肿瘤转化
- 批准号:
09470231 - 财政年份:1997
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
VSMC机械感受器TRPM7调控H3S10p/NOTCH3促进冠状动脉侧支生成的作用与机制研究
- 批准号:82300366
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
原位矿化诱导中性粒细胞弹性蛋白酶ELANE介导Notch信号通路增效肺癌放疗的机制研究
- 批准号:82373199
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
苯并呋喃-6-酮类化合物TT01f通过调控Jagged1/Notch信号通路改善特发性肺纤维化的药理学机制研究
- 批准号:82304596
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SARS-CoV-2 N蛋白激活SCAP-SREBP2/Notch1信号通路促进动脉粥样硬化进展及其机制研究
- 批准号:82360101
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
按揉手法调控Notch1/Notch通路干预大鼠失神经支配骨骼肌卫星细胞再生潜能的研究
- 批准号:82374606
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
病原性共生菌へのNotch依存的特異免疫応答の解明と粘膜ワクチンへの応用研究
对致病共生菌的Notch依赖性特异性免疫反应的阐明及其在粘膜疫苗中的应用研究
- 批准号:
24K09802 - 财政年份:2024
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
糖転移酵素群によるNOTCHタンパク質の分泌・分解の仕分け機構の解明
阐明糖基转移酶分泌和降解 NOTCH 蛋白的分选机制
- 批准号:
23K24077 - 财政年份:2024
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
人工Notch受容体によるmicroRNAの発現とその心筋再生療法への応用
人工Notch受体表达microRNA及其在心肌再生治疗中的应用
- 批准号:
24K17571 - 财政年份:2024
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a new lung cancer therapy targeting a MAML3-Hh/NOTCH signaling pathway
开发针对 MAML3-Hh/NOTCH 信号通路的新型肺癌疗法
- 批准号:
23K08298 - 财政年份:2023
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
小細胞肺がんでのmTOR・NOTCH1・YAP1の相互関係解析と抗がん剤耐性克服の検証
mTOR、NOTCH1、YAP1在小细胞肺癌中的相互关系分析及克服抗癌耐药性的验证
- 批准号:
23K06777 - 财政年份:2023
- 资助金额:
$ 29.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)